Through our infrastructure, patients can access experienced specialist prescribers, a reliable source of information and high-quality, affordable unlicensed medicines.
As an ethical company, we support unlicensed medicines. Our purpose is that ever-increasing numbers of patients and practitioners are able to easily access trusted information and bespoke treatments from a professional source.
At Medisonal, we are dedicated to providing our customers with the highest quality medical and healthcare supplies for a variety of needs.
Our comprehensive range of products and services includes our virtual clinic and pharmacy, as well as education and training for consultants, GPs and patients. We also provide a technology–based matching service, giving access to a network of GMC–registered consultants and clinicians with expertise in prescribing personalised treatments.
We are committed to providing the best customer service possible and advancing healthcare through innovative research and development. Our goal is to ensure that patients receive the best possible care and treatment, allowing them to lead healthier, happier lives.
We provide bespoke education programs for practitioners to increase their understanding of the effectiveness of unlicensed medicines for conditions where there is clear evidence that these medicines can have a positive impact. The educational programme we offer is based on expertise gained through research and clinical trials, and designed to help practitioners become more comfortable with unlicensed medicines
Our online portal enables both patients and medical practitioners to learn more about unlicensed medicines and their advantages over other forms of medication. This portal provides a secure environment within which multi-disciplinary practitioners can get and share information, ideas and reassurance.
We are developing partnerships with a number of teaching hospitals in the UK and abroad to contribute to clinical studies on the medical efficacy of unlicensed medicines in the treatment of specific conditions, and will work with all UK medical bodies, Government agencies and lobbying groups.
We strive to remain current, collaborative and influential on the future of unlicensed medicines acceptance and their wider use to help make a difference to patients’ lives.
